Reducing aspirin to one month after a heart attack lowers bleeding risk without increasing cardiovascular complications.
A study led by the Clínic Barcelona Comprehensive Cancer Center —a center driven by Clínic-IDIBAPS and the University of Barcelona (UB)— demonstrates1
A systematic review published in eClinicalMedicine concludes that most antidepressants, when used appropriately, do not significantly increase the ri1
Researchers from Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Center, and the spin-off Gyala Therapeutics have coordinated a stud1
Researchers from Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Center, have led a study analyzing how genetic mut1
An international team led by the Clínic-IDIBAPS and the Institute of Cancer Research in London has developed an innovative new method based on DNA me1
A study by the Clínic – IDIBAPS, carried out with mice, explores the therapeutic potential of this natural compound.
The company has secured 1.2 million euros from the Ministry of Science, Innovation and Universities’ call for public-private collaboration projects t1
Ferran Nadeu, a researcher in the IDIBAPS research group Molecular pathology of lymphoid neoplasms located at Esther Koplowitz Centre1
Twenty-five years ago, Catalonia pioneered the launch of the first colorectal cancer screening programme in Spain. The first studies had appeared sho1